Form 8-K - Current report:
SEC Accession No. 0001641172-25-011084
Filing Date
2025-05-15
Accepted
2025-05-15 17:25:05
Documents
14
Period of Report
2025-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 39111
2 EX-99.1 ex99-1.htm EX-99.1 74489
  Complete submission text file 0001641172-25-011084.txt   299784

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vvos-20250515.xsd EX-101.SCH 3006
4 XBRL LABEL FILE vvos-20250515_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE vvos-20250515_pre.xml EX-101.PRE 22353
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3808
Mailing Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120
Business Address 7921 SOUTHPARK PLAZA, SUITE 210 LITTLETON CO 80120 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39796 | Film No.: 25955940
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)